ICYMI. Weekly Stock Market Recap. Dec 10-14


16-Dec-2018 15:11 PM



In case you missed it, this past week stock market movers news and update. 

Monday the U.S. continues the sell-off early in the day with Dow Jones -500 points, but make a recovery back to close green up +33.90 points, SPY +0.19%, IWM -0.28%, QQQ +1.05%, IBB +0.17%.

  • Marinus Pharmaceuticals Inc (MRNS) clinical data update
  • Apple inc (AAPL) China court bans import sales, the stock took an early hit

Tuesday stock market closed with Dow Jones -53.02 points, SPY +0.02%, QQQ +0.33%, IWM -0.10%, IBB +0.34%

  • Intracellular Therapies Inc (ITCI) FDA accepts NDA for  Lumateperone, PDUFA 9/27/19. Our FDA PDUFA calendar here
  • Acorda Therapeutics Inc (ACOR) Goldman Sach downgraded to sell, PT $10
  • Alphabet Class A (GOOGL) chief to testify at the House Judiciary Committee
  • Corcept Therapeutics Inc (CORT) intraday strength due to patent issuance. stock up +32.28%
  • NVIDIA Corp (NVDA)  Softbank plans sales of a stake in Nvidia next year, stock down -2.34%

Wednesday the progress of U.S. and China trade talks cheer Wall Street with Dow Jones +300 points at the opening bell. Dow Jones closed +159.14 points, SPY +0.53%, QQQ +0.88%, IWM +0.96%, IBB +1.26%.

  • Neurocine Biosciences Inc (NBIX) phase 2b T-Force GOLD study did not meet the primary endpoint
  • AC Immune SA (ACIU) license and collaboration with Eli Lilly and Co (LLY)
  • Sparton Corp (SPA) to be acquired  by Cerberus Capital Management for $18.50 per share in cash

Thursday Dow Jones closed up +70.11 points, SPY -0.03%, QQQ +0.03%, IWM -1.42%, IBB +1.51%.

  • Apple inc (AAPL) to build $1 billion campus in Austin, Tx
  • Akebia Therapeutics Inc (AKBA) complete merger with KERX to fully integrated renal company
  • Applied Genetic Technologies Corporation (AGTC) topline interim Phase 1/2 X-linked Retinoschisis did not demonstrate signs of clinical activity at six-month.
  • Wynn Ltd (WYNN) and Las Vegas Sands Corp (LVS) Jim Chanos short the stock via CNBC


  • Johnson and Johnson (JNJ) knew for decades of asbestos in baby powder, failed to tell FDA. -Reuters
  • Idera Pharmaceuticals (IDRA) clinical data update ILLUMINATE-204, stock down -39.70%

Contact us:

Twitter: @BiotechMoney18




Add Your Comment

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.